- Home
- LXRX vs PMX Comparison
LXRX vs PMX Comparison
Compare LXRX & PMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- PMX
- Stock Information
- Founded
- LXRX 1995
- PMX 2002
- Country
- LXRX United States
- PMX United States
- Employees
- LXRX N/A
- PMX N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- PMX Trusts Except Educational Religious and Charitable
- Sector
- LXRX Health Care
- PMX Finance
- Exchange
- LXRX Nasdaq
- PMX Nasdaq
- Market Cap
- LXRX 283.7M
- PMX 243.2M
- IPO Year
- LXRX 2000
- PMX N/A
- Fundamental
- Price
- LXRX $0.71
- PMX $7.46
- Analyst Decision
- LXRX Buy
- PMX
- Analyst Count
- LXRX 2
- PMX 0
- Target Price
- LXRX $4.00
- PMX N/A
- AVG Volume (30 Days)
- LXRX 4.1M
- PMX 101.5K
- Earning Date
- LXRX 03-10-2025
- PMX 01-01-0001
- Dividend Yield
- LXRX N/A
- PMX 5.28%
- EPS Growth
- LXRX N/A
- PMX N/A
- EPS
- LXRX N/A
- PMX N/A
- Revenue
- LXRX $5,229,000.00
- PMX N/A
- Revenue This Year
- LXRX $842.94
- PMX N/A
- Revenue Next Year
- LXRX $19.76
- PMX N/A
- P/E Ratio
- LXRX N/A
- PMX N/A
- Revenue Growth
- LXRX 886.60
- PMX N/A
- 52 Week Low
- LXRX $0.62
- PMX $6.09
- 52 Week High
- LXRX $2.83
- PMX $8.47
- Technical
- Relative Strength Index (RSI)
- LXRX 43.33
- PMX 55.76
- Support Level
- LXRX $0.66
- PMX $7.35
- Resistance Level
- LXRX $0.97
- PMX $7.42
- Average True Range (ATR)
- LXRX 0.07
- PMX 0.08
- MACD
- LXRX -0.00
- PMX 0.01
- Stochastic Oscillator
- LXRX 16.13
- PMX 82.76
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About PMX PIMCO Municipal Income Fund III of Beneficial Interest
PIMCO Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as transportation, healthcare, and others.